Permira acquires Neuraxpharm, European CNS specialty pharmaceutical company

Today, the company has annual revenues in excess of €460 million ($540 million) and 850 employees.

22 September 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles